When most people hear about GLP-1 medications such as semaglutide or tirzepatide, they immediately think about weight loss. But weight reduction is only part of the story. Research over the past several years has shown that medications affecting the GLP-1 pathway may...
If you’ve heard about Zepbound® (tirzepatide) and are wondering whether Medicare will help pay for it in 2026, you’re not alone. Millions of older Americans struggle with obesity and its complications, including heart disease, sleep apnea, arthritis, high...
Why Are GLP-1 Medications Helping So Many Different Medical Conditions? For years, GLP-1 medications such as semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®) were viewed primarily as weight-loss or diabetes medications. Today, researchers are...
For many people, GLP-1 medications are known simply as “weight-loss injections.” While weight reduction is certainly an important benefit, research over the last several years has revealed something much more remarkable. Scientists now recognize that GLP-1...
Over the past several years, GLP-1 medications have transformed the treatment of obesity and Type 2 diabetes. While many people recognize these medications for their ability to promote significant weight loss, researchers have discovered that their benefits extend far...
For many people, losing weight isn’t simply a matter of eating less and exercising more. Obesity is now recognized as a chronic medical condition influenced by genetics, hormones, metabolism, medications, stress, sleep, and lifestyle. Fortunately, advances in...
